The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke

Overview of attention for article published in BMC Neurology, May 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 2 news outlets

twitter: 1 X user

Citations

dimensions_citation: 45 Dimensions

Readers on

mendeley: 119 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Tenecteplase on Par With Alteplase, Randomized Trial Affirms

MedPage Today, 09 Feb 2023

Meeting Coverage > ISC Data from China strengthen the evidence base for off-label use by Crystal Phend, Contributing Editor…

AVC thrombolysé : le tenecteplase substituable à l’alteplase

Medscape, 05 Jun 2017

Prague, République Tchèque — Le tenecteplase (Metalyse®, Boehringer Ingelheim), se montre non inférieur à l’alteplase (Actilyse®…